A CCL-14 concentration of 1.3 ng/mL achieved 91% sensitivity and identified the vast majority of patients who develop persistent severe AKI, with a negative predictive value of 92%, making it valuable for ruling out disease progression. The gene discussed is CCL14; the disease is acute kidney injury.